Sensei Biotherapeutics, Inc.
Nasdaq: SNSEPharmaceutical Preparations · Entity-resolved by Clous
CIK0001829802
TickerSNSE
ExchangeNasdaq
SIC2834
StateDE
FY end12-31
Illustrative profile — live data lights up when a server API key is configured.
Key financials
Revenue
—
—
Net IncomeFY2025-12-31
-$21.09M
+30.1% YoY
Total AssetsFY2025-12-31
$22.9M
-49.5% YoY
EquityFY2025-12-31
$18.59M
-51.6% YoY
Shares OutstandingFY2025-12-31
1.34M
—
Operating Cash FlowFY2025-12-31
-$20.45M
+17.1% YoY
Market
Market
SNSEClose price
$36.16
Market cap
$48.52M
delayed EOD · as of 2026-07-10
Short interest & fails
Cost to borrow175.86%20K shares availablehard to borrow
Fails-to-deliver
SEC CNS fails · semi-monthly9.56K
shares failed · 2026-06-16
2026-06-169.56K sh$13.85
2026-06-1515.05K sh$13.00
2026-06-129.76K sh$10.79
2026-06-112.2K sh$11.41
2026-06-104.52K sh$12.63
Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.
| Concept | FY2022-12-31 | FY2023-12-31 | FY2024-12-31 | FY2025-12-31 | YoY | % rev |
|---|---|---|---|---|---|---|
| Net Income | -$48.59M | -$34.1M | -$30.16M | -$21.09M | +30.1% | — |
| Total Assets | $118.38M | $74.37M | $45.36M | $22.9M | -49.5% | — |
| Equity | $103.41M | $64.9M | $38.39M | $18.59M | -51.6% | — |
| Operating Cash Flow | -$39.03M | -$32.02M | -$24.67M | -$20.45M | +17.1% | — |
| Shares Outstanding | — | — | — | 1.34M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0001829802